US Stock MarketDetailed Quotes
CMRX Chimerix
- 0.914
- +0.034+3.83%
Close Nov 21 16:00 ET
82.17MMarket Cap-972P/E (TTM)
0.943High0.870Low143.09KVolume0.870Open0.880Pre Close131.66KTurnover0.19%Turnover RatioLossP/E (Static)89.94MShares1.30052wk High0.61P/B68.58MFloat Cap0.75052wk Low--Dividend TTM75.06MShs Float58.040Historical High--Div YieldTTM8.25%Amplitude0.750Historical Low0.920Avg Price1Lot Size
About Chimerix Company
Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded in April 2000 and is headquartered in Durham, NC.
Company Profile
SymbolCMRX
Company NameChimerix
Listing DateApr 11, 2013
Issue Price14.00
Founded2000
CEOMr. Michael T. Andriole
MarketNASDAQ
Employees72
Fiscal Year Ends12-31
Address2505 Meridian Parkway,Suite 100
CityDurham
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27713
Phone1-919-806-1074
Websitehttp://www.chimerix.com
Company Executives
- Name
- Position
- Salary
- Michael T. Andriole
- Director, Chief Executive Officer and President
- 1.31M
- Michelle LaSpaluto
- Chief Financial Officer
- --
- Dr. Allen S. Melemed
- Chief Medical Officer
- 931.79K
- Thomas J. Riga
- Chief Operating Officer and Chief Commercial Officer
- --
- David Jakeman
- Vice President, Finance and Accounting and Principal Accounting Officer
- --
- Dr. Michael A. Alrutz,PhD
- Senior Vice President, General Counsel and Corporate Secretary
- 793.85K
- Michael Sherman
- Chairman of the Board
- 1.52M
- Marc D. Kozin
- Director
- --
- Martha J. Dei
- Lead Independent Director
- 144.52K
- Dr. Pratik S. Multani, M.D.
- Independent Director
- 104.52K
- Patrick C. Machado, J.D.
- Independent Director
- 124.52K
- Victoria Vakiener
- Independent Director
- 107.02K
- Dr. Robert J. Meyer, M.D.
- Independent Director
- 117.02K
- Lisa Lynn Decker, PhD
- Independent Director
- 67.78K
- Fred A. Middleton
- Independent Director
- 119.52K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
